Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening.
about
Developments in Screening Tests and Strategies for Colorectal CancerColorectal Cancer Screening in Average Risk Populations: Evidence SummaryFecal-based colorectal cancer screening among the uninsured in northern Manhattan.Advances in Fecal Occult Blood Tests: the FIT revolution.Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programmeUsing the Cancer Risk Management Model to evaluate colorectal cancer screening options for CanadaCost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA.Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina.Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.Quality of life in participants of a CRC screening programA Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death.Colorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities.The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).FIT testing: an overview.Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature.CT colonography: accuracy, acceptance, safety and position in organised population screening.Faecal occult blood testing for colorectal cancer screening: the past or the future.Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.FITting ADR to colonoscopy indication.Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.Attendance and yield over three rounds of population-based fecal immunochemical test screening.Screening: Colorectal cancer screening--insights and challenges.Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea.Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness-A modeling study.Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study.The fecal immunochemical test (fit): Selected aspects regarding its effectiveness for colorectal cancer screening in Quebec City
P2860
Q26778581-C91210FF-3774-44D9-A152-834BCA15B429Q28080279-4B3C96F4-6222-4DB2-821A-1EFF7FC07295Q34024874-5219FA21-0E31-4958-966E-455290AA28D4Q34666990-10974AED-EC76-499A-B292-C90947CFD10FQ35048575-98051C23-FF24-42BD-A656-48B0CB0969C7Q35445134-6662F301-DCDC-4FE6-8ECA-C33122A8E8FDQ35633134-1251E3BA-BA0D-4130-A4CC-E46131F7B6DAQ35670730-FED1D3EF-512A-4359-AAAF-92F2E6389053Q36021151-BD21F2EF-9B48-41F9-9825-454F31A81C64Q36387839-18092A41-D195-4568-A73A-3779BEFF7D4EQ36534739-ED79276D-FD7C-4988-96BB-68ADF5AFB64AQ37293249-37D588BB-E9E8-42BB-9E8E-BA002F224058Q37507961-F65C5F80-E11F-421B-A9B3-B6A2D8D133B9Q37600878-966AFD6F-0CED-468E-A14C-B716729055DFQ37660378-8136C070-515F-46C6-98CA-251D953EB35CQ38161843-388FBD16-A407-478F-9BBD-F231A2D7B31FQ38246448-8E326E2C-72BB-42A1-95F4-FA0D2653E0E7Q38281894-2BE34BB6-4448-45A1-93B5-970BC452D27AQ38352369-433F2AF6-0333-4D45-BAB6-96581458F108Q38983778-1E66BAD3-2F30-436A-A144-C9F0018D885EQ40540045-95E22B77-7196-4486-AAE7-81F77E4E2DCBQ42316586-39C6FEAE-1040-46D9-AC0B-F46C9423DD00Q42709638-9F2B7B9A-21A2-4230-90AA-0AD8C446C8F8Q44620703-5CC97ACE-56FC-4636-A157-9980FE046DAFQ45469786-CEC377D0-A4DC-4B36-AA7E-ED8D3619E793Q47168165-D1E1F109-2E7D-4A83-A86C-C96ED49B7108Q47199296-01B748AB-2110-4864-9252-405760BF4815Q53475176-6F43DC03-A0D7-4199-9596-391E87C2A6A4Q53619735-D5E2586C-37CF-40E9-BE2B-813B95F84897Q53641096-35637450-7C7D-4179-A57F-55E6CC5C49A3Q58800662-460F3EC7-2610-4247-BAB3-7985DE8D82A0
P2860
Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Random comparison of repeated ...... d colorectal cancer screening.
@en
Random comparison of repeated ...... d colorectal cancer screening.
@nl
type
label
Random comparison of repeated ...... d colorectal cancer screening.
@en
Random comparison of repeated ...... d colorectal cancer screening.
@nl
prefLabel
Random comparison of repeated ...... d colorectal cancer screening.
@en
Random comparison of repeated ...... d colorectal cancer screening.
@nl
P2093
P1433
P1476
Random comparison of repeated ...... d colorectal cancer screening.
@en
P2093
Aafke H C van Roon
Alexandra C M van der Togt
Anneke J van Vuuren
Caspar W N Looman
Hans 't Mannetje
J Dik F Habbema
Jacqueline C I Y Reijerink
Katharina Biermann
Monique E van Leerdam
S Luuk Goede
P304
P356
10.1136/GUTJNL-2011-301583
P407
P577
2012-03-02T00:00:00Z